Download Regulatory File Checklist

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
INDUSTRY SPONSOR REGULATORY BINDER
DOCUMENTS TO BE
MAINTAINED:
 COPIES OF THE FOLLOWING SHOULD BE RETAINED IN FILE OR MAINTAINED ELECTRONICALLY IN
MYIRB SYSTEM
CURRICULUM VITAES FOR THE PRINCIPAL INVESTIGATOR AND ALL PHYSICIAN SUBINVESTIGATORS LISTED ON THE FORM FDA 1572. THESE MUST BE CURRENT (LESS THAN TWO
YEARS OLD).
CURRICULUM VITAES FOR ALL RESEARCH COORDINATORS AND RESEARCH NURSES INVOLVED IN
THE STUDY (LESS THAN TWO YEARS OLD)
CURRENT MEDICAL LICENSES FOR THE RESEARCH STAFF (ALL APPLICABLE):
 Principal Investigator (if MD)
 Co-Investigators (if MDs, nurses, etc)
 All others, ex: PTs, RTs, RRTs, RPh
COMPLETED AND SIGNED FORM FDA 1572

Send original to Sponsor

Retain copy in file
PROTOCOL SIGNATURE PAGE

Send original to Sponsor

Retain copy in file
INVESTIGATOR BROCHURE

Send signed acknowledgement of receipt to Sponsor

Retain copy in file
LABORATORY CERTIFICATIONS AND NORMAL REFERENCE RANGES

Local Laboratory CAP/CLIA Certifications

Director CV and license

Normal Reference Ranges

Updated Lab information

Retain copy in file
IRB INITIAL SUBMISSION APPLICATION
Feb. 2014
INDUSTRY SPONSOR REGULATORY BINDER
 FOLLOW INSTRUCTIONS PER MYIRB AND SUBMIT APPLICABLE DOCUMENTS

Current Version of Protocol (with version number and date)

Completed IRB Application

Consent Form (with version number and date in footer)
Include all versions – short forms, verbal scripts, assents, consents

All data collection instruments relevant to study

All other information administered/provided to subjects; e.g: diaries, questionnaires

Certificate of Confidentiality, if required
IRB CORRESPONDENCE

PI Correspondence Report Form

Approval Memo and supporting documentation (i.e. Waiver of HIPAA Authorization)
STUDY COMMUNICATION
 Date of conversation
 Name of people engaged in this conversation & affiliation
 Include brief description of conversation
 Means: email, phone, person to person, fax
 If applicable: copy of email
 Note: any follow-up required (by CRC/PI)
File correspondence in appropriate location, e.g.: subject record or regulatory binder, appropriate section
DURING THE CLINICAL TRIAL
IRB MODIFICATION UPDATE FORM

Submit and Maintain Modification Update Form

Approval Memo and supporting documentation
REPORTABLE EVENT FORM

Submit and Maintain Reportable Event Form

Maintain and file Study specific event report form(s): IND Safety Reports; Med Watch Forms,
if applicable
STUDY RECRUITMENT
 ALL STUDY RECRUITMENT MATERIALS NEED TO BE SUBMITTED TO IRB
Feb. 2014
INDUSTRY SPONSOR REGULATORY BINDER

E.g. Advertisements, press releases, letters to colleagues, letter to participants
IRB CONTINUING REVIEW
 FOLLOW INSTRUCTIONS PER MYIRB AND SUBMIT APPLICABLE DOCUMENTS

Complete myIRB Continuing Review Form
END OF STUDY FORMS
PROJECT CLOSE FORM
 FOLLOW INSTRUCTIONS PER MYIRB AND SUBMIT APPLICABLE DOCUMENTS

Submit and Maintain Project Close Form
 CONSIDER THE FOLLOWING DOCUMENTATION FORMS FOR DATA
COLLECTION

Inclusion/Exclusion check off

Case report forms

Copy of Note-to-File to be used

Screening log

Enrollment log

Master ID list: Code linking participant with a subject ID

Shipping log of Investigational Product

Receipt log of Investigational Product

Temperature log

Dispensing log of Investigational Product
 REMINDER: KEEP CURRENT STUDY DOCUMENTS E.G. Laboratory
Certification/Accreditation/Values; CVs, License
Feb. 2014
INDUSTRY SPONSOR REGULATORY BINDER
Feb. 2014